0

Journal Articles

in Nutrition/Metabolic Disorders
 101-120 of 891 Articles
Commentary |  November 16, 2011
Cardiovascular Science in the Service of National Strength
JAMA. 2011;306(19):2145-2146. doi:10.1001/jama.2011.1669.
Commentary |  November 16, 2011
The Cardiovascular Biomarker Conundrum:  Challenges and Solutions
Vinay Prasad, MD; Robert O. Bonow, MD
JAMA. 2011;306(19):2151-2152. doi:10.1001/jama.2011.1673.
Editorial |  November 16, 2011
High-Density Lipoprotein Cholesterol as the Holy Grail
Christopher P. Cannon, MD
JAMA. 2011;306(19):2153-2155. doi:10.1001/jama.2011.1687.
Original Contribution |  November 16, 2011 FREE
Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol:  A Randomized Controlled Trial
Stephen J. Nicholls, MBBS, PhD; H. Bryan Brewer, MD, PhD; John J. P. Kastelein, MD, PhD; et al.
JAMA. 2011;306(19):2099-2109. doi:10.1001/jama.2011.1649.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  November 16, 2011
Statin Therapy in Primary CVD Prevention Remains a Hot-button Topic for Some
JAMA. 2011;306(19):2077-2078. doi:10.1001/jama.2011.1664.
Capitol Health Call |  November 09, 2011
Animal Antibiotic Use
Mike Mitka
JAMA. 2011;306(18):1970. doi:10.1001/jama.2011.1601.
Global Health |  October 19, 2011
Vitamin A Supplementation
M. J. Friedrich
JAMA. 2011;306(15):1644. doi:10.1001/jama.2011.1483.
Caring for the Critically Ill Patient |  October 12, 2011 FREE
Enteral Omega-3 Fatty Acid, γ-Linolenic Acid, and Antioxidant Supplementation in Acute Lung Injury
Todd W. Rice, MD, MSc; Arthur P. Wheeler, MD; B. Taylor Thompson, MD; et al.
JAMA. 2011;306(14):1574-1581. doi:10.1001/jama.2011.1435.
INCLUDES: , Supplemental Content
Commentary |  October 12, 2011
Improving the Food and Drug Administration's Mandate to Ensure Postmarketing Drug Safety
Dima M. Qato, PharmD, MPH, PhD; G. Caleb Alexander, MD, MS
JAMA. 2011;306(14):1595-1596. doi:10.1001/jama.2011.1457.
Original Contribution |  October 12, 2011 FREE
Vitamin E and the Risk of Prostate Cancer:  The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Eric A. Klein, MD; Ian M. Thompson, MD; Catherine M. Tangen, DrPH; et al.
JAMA. 2011;306(14):1549-1556. doi:10.1001/jama.2011.1437.
JAMA Patient Page |  October 12, 2011 FREE
Celiac Disease
Huan J. Chang, MD, MPH; Alison E. Burke, MA; Robert M. Golub, MD
JAMA. 2011;306(14):1614. doi:10.1001/jama.306.14.1614.
INCLUDES: , Supplemental Content
Clinical Crossroads |  October 12, 2011
Celiac Disease Diagnosis and Management:  A 46-Year-Old Woman With Anemia
Daniel Leffler, MD, MS
JAMA. 2011;306(14):1582-1592. doi:10.1001/jama.2011.1312.
INCLUDES: CME
Lab Reports |  October 05, 2011
Diet and Diabetes Link
Tracy Hampton, PhD
JAMA. 2011;306(13):1431. doi:10.1001/jama.2011.1391.
JAMA Patient Page |  October 05, 2011 FREE
Irritable Bowel Syndrome
Janet M. Torpy, MD; Robert M. Golub, MD
JAMA. 2011;306(13):1501. doi:10.1001/jama.306.13.1501.
INCLUDES: , Supplemental Content
Commentary |  September 28, 2011
The Supplemental Nutrition Assistance Program, Soda, and USDA Policy:  Who Benefits?
Kelly D. Brownell, PhD; David S. Ludwig, MD, PhD
JAMA. 2011;306(12):1370-1371. doi:10.1001/jama.2011.1382.
Commentary |  September 21, 2011
The FDA—A Misunderstood Agency
Joshua M. Sharfstein, MD
JAMA. 2011;306(11):1250-1251. doi:10.1001/jama.2011.1345.
Preliminary Communication |  September 14, 2011 FREE
Association Between Serum Cathepsin S and Mortality in Older Adults
Elisabeth Jobs, MSc; Erik Ingelsson, MD, PhD; Ulf Risérus, MMed, PhD; et al.
JAMA. 2011;306(10):1113-1121. doi:10.1001/jama.2011.1246.
INCLUDES: , Supplemental Content
Original Contribution |  August 24, 2011 FREE
Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia:  A Randomized Controlled Trial
David J. A. Jenkins, MD; Peter J. H. Jones, PhD; Benoit Lamarche, PhD; et al.
JAMA. 2011;306(8):831-839. doi:10.1001/jama.2011.1202.
INCLUDES: , Supplemental Content
Original Contribution |  August 17, 2011 FREE
Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment:  Two Randomized Controlled Trials
JAMA. 2011;306(7):711-720. doi:10.1001/jama.2011.1169.
INCLUDES: , Supplemental Content
Lab Reports |  August 03, 2011
Fat Stem Cells
Tracy Hampton, PhD
JAMA. 2011;306(5):480. doi:10.1001/jama.2011.1088.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  May 13, 2013
Changes in Sodium Levels in Processed and Restaurant Foods, 2005 to 2011
Michael F. Jacobson, PhD; Stephen Havas, MD, MPH, MS; Robert McCarter, ScD
JAMA Internal Medicine
Original Investigation  |  May 13, 2013
The Energy Content of Restaurant Foods Without Stated Calorie Information
Lorien E. Urban, PhD; Alice H. Lichtenstein, DSc; Christine E. Gary, MS; et al.
JAMA Internal Medicine
Research Letters  |  May 13, 2013
Restaurant Meals: Almost a Full Day's Worth of Calories, Fats, and Sodium
Mary J. Scourboutakos, BSc; Zhila Semnani-Azad; Mary R. L’Abbe, PhD
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems